author-photo

Julia Hatto

Novartis

13

Papers

226

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Correction to “Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma”

2017 ACS Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (1)
Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma.

2017 ACS Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (21)
Early Process Development of a Squaramide-Based CXCR2 Receptor Antagonist

2015 Organic Process Research & Development
Show All
- Source
- Cite
- Save
Citations (6)
Discovery and Optimization of 4-(8-(3-Fluorophenyl)-1,7-naphthyridin-6-yl)transcyclohexanecarboxylic Acid, an Improved PDE4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).

2015 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (7)
The identification of 7-[(R)-2-((1S,2S)-2-benzyloxycyclopentylamino)-1-hydroxyethyl]-4-hydroxybenzothiazolone as an inhaled long-acting β2-adrenoceptor agonist

2014 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (1)
Composés organiques de thiazolyle

2006
Show All
- Source
- Cite
- Save
Citations (0)
Composés organiques de thiazolyle

2006
Show All
- Source
- Cite
- Save
Citations (0)
A new orally bioavailable dual adenosine A2B/A3 receptor antagonist with therapeutic potential

2005 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (33)